Is Comparative Effectiveness Antithetical to Personalized Medicine?

Critics of comparative clinical effectiveness argue that the research, which relies in part on large-scale clinical trials, directly conflicts with personalized medicine's focus on patient sub-populations. Can the two peacefully co-exist?